|Bid||67.40 x 1000|
|Ask||80.67 x 800|
|Day's Range||71.47 - 73.74|
|52 Week Range||42.85 - 73.81|
|Beta (5Y Monthly)||1.06|
|PE Ratio (TTM)||60.93|
|Earnings Date||Aug 03, 2021 - Aug 09, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||77.73|
Bruker's (BRKR) robust performances across segments and geographies manage to drive its Q1 sales despite pandemic-led business challenges.
Globus Medical (GMED) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Globus Medical's (GMED) first-quarter 2021 revenues improved year over year on strength in Enabling Technologies and U.S. Spine.